Peripheral metabolism of branched-chain keto acids in patients with chronic renal failure
- PMID: 8345831
Peripheral metabolism of branched-chain keto acids in patients with chronic renal failure
Abstract
Peripheral tissue metabolism of branched-chain amino acids (BCAA) and branched-chain keto acids (BCKA) in the postabsorptive state was evaluated in 8 patients with chronic renal failure (CRF) and 7 controls by measuring the arterial-deep forearm venous differences for BCAA and BCKA. Arterial whole blood levels of BCAA and BCKA were also measured in an additional 7 patients and 11 controls. In CRF, total BCKA levels are reduced owing to a decrease in ketoisocaproic acid (KICA) and ketoisovaleric acid (KIVA) levels, parallel to changes in BCAA levels, whereas levels of ketomethylvaleric acid (KMVA) are not different from controls. Both in normal conditions and in patients, arterial levels of individual BCAA are directly correlated with arterial levels of the corresponding BCKA. However, in CRF, the ratios of leucine to KICA and of isoleucine to KMVA are increased. A direct correlation between KICA and HCO3- levels is observed. In CRF, the release of leucine and valine as well as of KICA and KMVA from peripheral tissues is reduced, whereas KIVA is neither released nor taken up by the forearm. The lack of KICA release from peripheral tissues likely accounts for its low circulating levels. The depressed peripheral release of leucine associated with the lack of KICA release suggests an increased degradation of leucine which proceeds beyond the transamination step.
Similar articles
-
Pharmacokinetic and metabolic interrelationships among branched-chain keto and amino acids in humans.J Lab Clin Med. 1985 Dec;106(6):701-7. J Lab Clin Med. 1985. PMID: 4067381
-
Branched-chain amino acid metabolism in chronic renal failure.Kidney Int Suppl. 1983 Dec;16:S17-22. Kidney Int Suppl. 1983. PMID: 6588248
-
Metabolism of orally administered branched-chain alpha-keto acids.Kidney Int Suppl. 1983 Nov;15:S11-5. Kidney Int Suppl. 1983. PMID: 6368946 Clinical Trial.
-
The role of skeletal muscle in the pathogenesis of altered concentrations of branched-chain amino acids (valine, leucine, and isoleucine) in liver cirrhosis, diabetes, and other diseases.Physiol Res. 2021 Jul 12;70(3):293-305. doi: 10.33549/physiolres.934648. Epub 2021 May 12. Physiol Res. 2021. PMID: 33982576 Free PMC article. Review.
-
Application of branched-chain amino acids in human pathological states: renal failure.J Nutr. 2006 Jan;136(1 Suppl):299S-307S. doi: 10.1093/jn/136.1.299S. J Nutr. 2006. PMID: 16365103 Review.
Cited by
-
Metabolite, protein, and tissue dysfunction associated with COVID-19 disease severity.Sci Rep. 2022 Jul 16;12(1):12204. doi: 10.1038/s41598-022-16396-9. Sci Rep. 2022. PMID: 35842456 Free PMC article.
-
Anti-sarcopenic effect of leucine-enriched branched-chain amino acid supplementation among elderly chronic kidney disease patients: a double-blinded randomized controlled trial.Int Urol Nephrol. 2025 May 17. doi: 10.1007/s11255-025-04560-9. Online ahead of print. Int Urol Nephrol. 2025. PMID: 40381110
-
Low-protein diets for chronic kidney disease patients: the Italian experience.BMC Nephrol. 2016 Jul 11;17(1):77. doi: 10.1186/s12882-016-0280-0. BMC Nephrol. 2016. PMID: 27401096 Free PMC article.
-
Urinary Metabolomic Markers of Protein Glycation, Oxidation, and Nitration in Early-Stage Decline in Metabolic, Vascular, and Renal Health.Oxid Med Cell Longev. 2019 Nov 19;2019:4851323. doi: 10.1155/2019/4851323. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 31827677 Free PMC article.
-
Low Valine Serum Levels Predict Increased 1-Year Mortality in Acute Heart Failure Patients.Biomolecules. 2023 Aug 29;13(9):1323. doi: 10.3390/biom13091323. Biomolecules. 2023. PMID: 37759723 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical